Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer. | PeerJ | 2025 | 40034665 | PubTator, text mining | PubMed |
| Molecular dynamics simulation reveals structural insights into isozyme selectivity of carbonic anhydrase XII inhibitors in hypoxic tumor microenvironment. | Biochem Biophys Res Commun | 2025 | 39965264 | PubTator, text mining | PubMed |
| Spectroscopic (FT-IR and FT-Raman) and quantum chemical study on monomer and dimer of benznidazole from DFT and molecular docking approaches. | Heliyon | 2025 | 39916842 | PubTator, text mining | PubMed |
| Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity. | Int J Biol Macromol | 2025 | 39884639 | PubTator, text mining | PubMed |
| A series of benzensulfonamide derivatives as new potent carbonic anhydrase IX and XII inhibitors. | Future Med Chem | 2025 | 39878534 | PubTator, text mining | PubMed |
| Novel N-(3-(1-(4-sulfamoylphenyl)triazol-4-yl)phenyl)benzamide Derivatives as Potent Carbonic Anhydrase Inhibitors with Broad-Spectrum Anticancer Activity: Leveraging Tail and Dual-Tail Approaches. | J Med Chem | 2025 | 39818802 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the heterogeneity of myofibroblasts in wound repair. | Genomics | 2025 | 39706310 | PubTator, text mining | PubMed |
| New 7-hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies. | Arch Pharm (Weinheim) | 2025 | 39686882 | PubTator, text mining | PubMed |
| The value of a metabolic and immune-related gene signature and adjuvant therapeutic response in pancreatic cancer. | Front Genet | 2024 | 39867576 | PubTator, text mining | PubMed |
| Gene expression analysis of ovarian follicles and stromal cells in girls with Turner syndrome. | Mol Hum Reprod | 2024 | 39673521 | PubTator, text mining | PubMed |
| WTAP mediates IL-1β-induced chondrocyte injury by enhancing CA12 mRNA stability depending on m6A modification. | J Orthop Surg Res | 2024 | 39639339 | PubTator, text mining | PubMed |
| CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity. | Cell Stem Cell | 2024 | 39515331 | PubTator, text mining | PubMed |
| A comprehensive transcriptome characterization of individual nuclear receptor pathways in the human small intestine. | Proc Natl Acad Sci U S A | 2024 | 39475639 | PubTator, text mining | PubMed |
| [Detection of pathogenic gene mutations in thirteen cases of congenital bilateral absence of vas deferens infertility patients]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2024 | 39397452 | PubTator, text mining | PubMed |
| Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: Design, synthesis and in silico studies. | Bioorg Chem | 2024 | 39396453 | PubTator, text mining | PubMed |
| Malignant transformation of ovarian mature cystic teratoma with rupture, elevated serum CA199, CA12, CEA: A case report. | Medicine (Baltimore) | 2024 | 39287252 | PubTator, text mining | PubMed |
| Clean-label alternatives for food preservation: An emerging trend. | Heliyon | 2024 | 39247286 | PubTator, text mining | PubMed |
| Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors. | Bioorg Chem | 2024 | 39213797 | PubTator, text mining | PubMed |
| Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analyses. | Heliyon | 2024 | 39165965 | PubTator, text mining | PubMed |
| Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold. | Molecules | 2024 | 39064868 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=5